MICHELLE MAYEUR: Open Payments
NPI 1295280212 · RIVER RIDGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 74 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $506 · 2025 $1,748
Food & beverage: $1,748
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 9 | $266 |
| Novo Nordisk Inc | 5 | $206 |
| Otsuka America Pharmaceutical, Inc. | 9 | $197 |
| Fresenius USA Marketing, Inc. | 10 | $181 |
| Calliditas Therapeutics US Inc. | 9 | $180 |
| Mallinckrodt Hospital Products Inc. | 5 | $129 |
| Aurinia Pharma U.S., Inc. | 2 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
Products named: Vafseo, VELPHORO, TARPEYO, JYNARQUE, Wegovy, ACTHAR, LUPKYNIS, FARXIGA.
Industry payments across LA — which companies pay providers there.
